Saudi Ministry of Education to showcase innovations at 2025 Geneva International Exhibition    7,523 violators of residency, labor, and border security laws deported in a week    Video contradicts Israeli army account of deadly March 23 strike on Gaza paramedics    Saudi Arabia spends over $241 million to implement de-mining projects in 3 countries    Italy's Meloni government approves controversial security decree expanding police protections and penalties    Egypt submits new Gaza ceasefire and prisoner exchange proposal: Report    'Everything is possible' — Ronaldo focused on titles, not 1,000-goal milestone after Riyadh Derby win    Saudi, US military leaders discuss enhanced defense cooperation in Riyadh    King Salman Global Academy for Arabic Language launches program with Indiana University    Ronaldo brace powers Al Nassr past Al Hilal in Riyadh derby thriller    Ed Sheeran weaves Persian music into new song, Azizam    Al-Jadaan: Crown Prince's directives confirm government's ability to bring back balance to real estate market    Veteran Bollywood actor Manoj Kumar dies at 87    Foreign investors are allowed to engage in real estate business outside Makkah and Madinah Commercial speculation should not be the purpose of real estate transaction    Aubameyang fires Al Qadsiah into King's Cup final with stoppage-time winner over Al Raed    Musk's X is suing India, as Tesla and Starlink plan entry    Tesla sales plunge after backlash against Elon Musk    Danilo Pereira fires Al Ittihad into King's Cup final with dramatic stoppage-time double    Screen time in bed linked to insomnia, study finds    Mexico bans junk food in schools to fight childhood obesity epidemic    Sweet sales surge ahead of Eid as Saudi chocolate imports top 123 million kg in 2024    Bollywood actress vindicated over boyfriend's death after media hounding    Grand Mufti rules against posting prayers and preaching in mosques on social media    King Salman prays for peace and stability for Palestinians in Ramadan message King reaffirms Saudi Arabia's commitment to serving the Two Holy Mosques and pilgrims    Exotic Taif Roses Simulation Performed at Taif Rose Festival    Asian shares mixed Tuesday    Weather Forecast for Tuesday    Saudi Tourism Authority Participates in Arabian Travel Market Exhibition in Dubai    Minister of Industry Announces 50 Investment Opportunities Worth over SAR 96 Billion in Machinery, Equipment Sector    HRH Crown Prince Offers Condolences to Crown Prince of Kuwait on Death of Sheikh Fawaz Salman Abdullah Al-Ali Al-Malek Al-Sabah    HRH Crown Prince Congratulates Santiago Peña on Winning Presidential Election in Paraguay    SDAIA Launches 1st Phase of 'Elevate Program' to Train 1,000 Women on Data, AI    41 Saudi Citizens and 171 Others from Brotherly and Friendly Countries Arrive in Saudi Arabia from Sudan    Saudi Arabia Hosts 1st Meeting of Arab Authorities Controlling Medicines    General Directorate of Narcotics Control Foils Attempt to Smuggle over 5 Million Amphetamine Pills    NAVI Javelins Crowned as Champions of Women's Counter-Strike: Global Offensive (CS:GO) Competitions    Saudi Karate Team Wins Four Medals in World Youth League Championship    Third Edition of FIFA Forward Program Kicks off in Riyadh    Evacuated from Sudan, 187 Nationals from Several Countries Arrive in Jeddah    SPA Documents Thajjud Prayer at Prophet's Mosque in Madinah    SFDA Recommends to Test Blood Sugar at Home Two or Three Hours after Meals    SFDA Offers Various Recommendations for Safe Food Frying    SFDA Provides Five Tips for Using Home Blood Pressure Monitor    SFDA: Instant Soup Contains Large Amounts of Salt    Mawani: New shipping service to connect Jubail Commercial Port to 11 global ports    Custodian of the Two Holy Mosques Delivers Speech to Pilgrims, Citizens, Residents and Muslims around the World    Sheikh Al-Issa in Arafah's Sermon: Allaah Blessed You by Making It Easy for You to Carry out This Obligation. Thus, Ensure Following the Guidance of Your Prophet    Custodian of the Two Holy Mosques addresses citizens and all Muslims on the occasion of the Holy month of Ramadan    







Thank you for reporting!
This image will be automatically disabled when it gets reported by several people.



Lupin sets off down Indian pharma's long road to redemption
Published in Alriyadh on 09 - 07 - 2017

In 28 years in India's pharmaceuticals sector, Rajiv Desai has never been busier.
Most of the last six months on his desk calendar is marked green, indicating visits to the 12 plants of Lupin , India's No. 2 drugmaker, where Desai is a senior quality control executive. Only one day is red - a day off.
That's what is needed these days to satisfy the U.S. Food and Drug Administration that standards are being met.
"In this sector, you're only as good as your last inspection," Desai said in his office in suburban Mumbai.
Often dubbed "the pharmacy of the world", India is home to the most FDA-approved plants outside of the United States and supplies about 40 percent of the US$70 billion worth of generic drugs sold in the country.
But sanctions and bans have badly damaged India's reputation and slowed growth in the US$16 billion sector. Drug exports fell in the fiscal year ending in March 2017.
More than 40 plants have been banned by the FDA for issues ranging from data fraud to hygiene since India's then-largest drugmaker Ranbaxy was pulled up for serious violations in 2008.
Drug companies have spent millions of dollars on training, new equipment and foreign consultants. Yet the Indian Pharmaceutical Alliance of the top 20 firms says its members still need at least five more years to get manufacturing standards and data reliability up to scratch.
The case of Lupin, whose shares are down about 27 percent since 2015 compared to a 13 percent drop in the Nifty pharma index , shows why.
The FDA is in the next few months expected to clear Lupin's Goa plant, which supplies around a third of its U.S. sales, of problems found in 2015, Desai said.
However, the agency also published a new notice just last week citing issues with data storage at its plant in Pithampur, central India.
If companies want to continue to sell into the world's biggest health care market, they must keep constant vigilance.
Many in the industry expect to see consolidation among manufacturers after a wave of mergers among U.S. drug distributors and increasing price pressures.
"A lot of companies will struggle to meet the requirements that are the need of the day, and I would expect to see additional consolidation on the supply side," Lupin's Chief Executive Vinita Gupta told analysts last month.
Asked about Lupin's case, the FDA said in a statement it did not "comment on compliance matters", but said generally:
"India's regulatory infrastructure must keep pace to ensure that relevant quality and safety standards are met."
FORM 483
India has its own standards body, the Central Drug Standard Control Organisation (CDSCO), which maintains that its quality controls are stringent enough to ensure drugs are safe.
"India's standards are different," CDSCO head G.N. Singh said in an interview in his New Delhi office. "Indian companies are compliant with our manufacturing standards. We cannot regulate them according to the U.S. standards."
The FDA has taken matters into its own hands and gradually expanded in India to more than a dozen full-time staff.
Inspections are frequent and increasingly unannounced. If the agency finds problems, it issues a Form 483 – a notice outlining the violations - which if not resolved can lead to a "warning letter" and in worst case, a ban.
Violations range from hygiene, such as rat traps and dirty laboratories, to inadequate controls on systems that store data, leaving it open to tampering.
None of the violations the FDA has cited in India have explicitly said the drugs are unsafe, and when companies are banned by the FDA they can sell into other markets, including in the developing world, until the bans are lifted.
There are also no studies showing that the drugs have harmed anyone in the world. But by definition, the notices are issued when the FDA finds conditions that might harm public health.
DON'T TELL ANYONE
Industry watchers say Lupin, which specializes in oral contraceptives and drugs for diabetes and hypertension, is doing better than most. So far none of its infractions have extended to a ban.
On a recent visit by Reuters to its Goa plant, blue-uniformed employees could be seen working on giant machines, then making notes in hardbound registers. These are being phased out as Lupin transitions to more secure e-files.
Employees are often videotaped to ensure they follow standard operating procedure. Manufacturers have cut back to focus on quality over quantity: five years ago, Lupin was making one billion pills a month at one of its Goa plants. Now it makes just 450 million.
Both the company and employees needed to be willing to acknowledge errors, Desai said. The first impulse in the past was often "don't tell anyone", he said.
"We're humans after all, not robots. We make mistakes," said Amol Kolatkar, a production head at the Goa site.
As recently as three years ago, training was a "formality", Desai said. Now, when an error is traced to an employee, the entire team undergoes fresh training.
"I have worked at a pharma company before, but this is the first time I went through such a training," said another Lupin quality control officer, who asked not to be named because he was not authorized to speak to the media.
"They told us a lot about the Lupin culture and quality, and also stressed on good manufacturing practices."
The quality control role is key.
"They (Lupin) have had a practice where company's quality heads report directly to Nilesh Gupta (the managing director)," said Amey Chalke, an analyst at HDFC Securities. "Some other companies have also started doing that now."
The companies also have to be willing to spend big. Lachman, PwC and Boston Consulting conduct mock audits at the Goa plant every three to six months, at a cost of up to US$400 an hour.
"These days the FDA is giving us 483 on small, small things," a third quality control officer said. "So we are always auditing."


Clic here to read the story from its source.